Improving the Diagnostic Performance of 18F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography in Prosthetic Heart Valve Endocarditis
- Swart, Laurens E.
- Gomes, Anna
- Scholtens, Asbjørn M.
- Sinha, Bhanu
- Tanis, Wilco
- Lam, Marnix G. E. H.
- van der Vlugt, Maureen J.
- Streukens, Sebastian A. F.
- Aarntzen, Erik H. J. G.
- Bucerius, Jan
- van Assen, Sander
- Bleeker-Rovers, Chantal P.
- van Geel, Peter Paul
- Krestin, Gabriel P.
- van Melle, Joost P.
- Roos-Hesselink, Jolien W.
- Slart, Riemer H. J. A.
- Glaudemans, Andor W. J. M.
- Budde, Ricardo P. J.
Publication date
January 2018
DOI Publisher
Ovid Technologies (Wolters Kluwer Health) ISSN
0009-7322Abstract
BACKGROUND: 18F-Fluorodeoxyglucose (FDG) positron-emission tomography/computed tomography (PET/CT) was recently introduced as a new tool for the diagnosis of prosthetic heart valve endocarditis (PVE). Previous studies reporting a modest diagnostic accuracy may have been hampered by unstandardized image acquisition and assessment, and several confounders, as well. The aim of this study was to improve the diagnostic performance of FDG PET/CT in patients in whom PVE was suspected by identifying and excluding possible confounders, using both visual and standardized quantitative assessments
Add to ORKG